MG University Result 2025: Mahatma Gandhi University (MGU) Nalgonda has recently declared the semester results for various courses like BA, BSc, BCom, LLB, and other exams. Mahatma Gandhi ...

Researchers randomized 358 patients to receive atazanavir (300 mg) boosted by ritonavir (100 mg) once daily, atazanavir (400 mg) + saquinavir (1200 mg) once daily, or lopinavir/ritonavir (400mg ...

JSW MG Motor India has unveiled two new cars at the Bharat Mobility Global Expo 2025. Introducing the MG Cyberster, India’s first all-electric roadster, and the MG M9, the country’s first ...

The M9 positions MG in the premium electric MPV segment and will be offered exclusively through the brand's 'Select' dealerships MG to retail the premium M9 MPV via its new ‘Select’ dealerships.

MG’s most powerful EV yet comes with two motors and a single 77 kWh battery pack. The dual motor setup produces an output of 510 PS and 725 Nm, with a 0-100 km acceleration in 3.2 seconds.

The SV-R arrived in 2004 and had its Ford Modular V8 bored to 5.0-litres, with tuning by Roush to take power up to around 385bhp. MG claimed 376lb ft of torque too, with an ambitious 0-62mph time ...

If you’re looking for a budget tablet, then the Samsung Galaxy Tab A7 ... following a $60 discount on its original price of $100, but it's locked to a Straight Talk prepaid plan.

Examples of these drugs include: HIV drugs, such as ritonavir ... immediate-release tablet: 75 mg, 100 mg • oral extended-release tablet: 100 mg, 150 mg, 200 mg, 300 mg Wellbutrin XL ...

If you need an Android tablet for simple tasks like browsing the internet and watching streaming shows, the affordable Samsung Galaxy Tab A7 Lite may be enough for you. Its 8.7-inch screen is ...

Why not earn a little extra cash while you’re at it? With Chase Bank promotions, you can easily earn between $300 and $3,000 when you open a new account. To take advantage of these bonus offers ...

150 mg b.i.d. 303.40 (60 count) Abacavir (Ziagen, GlaxoSmithKline) 300 mg b.i.d. 407.70 (60 count) On October 14, 2003, Gilead Sciences sent a "Dear Health Care Professional" letter warning of the ...